ORACLE INVESTMENT MANAGEMENT INC Hedge Fund

CIK: 0001012622 · Show all filings

Period: Q1 2020 (← Previous) (Next →)

Filing Date: May 15, 2020

Total Value ($000): $336,565 (100.0% shares, 0.0% debt)

Holdings (19)

— QUIDEL CORP 52.5%

Value ($000) $176,643 Shares 1,805,983 Est. Cost $24542.18 Unrealized —

— BIOHAVEN PHARMACTL HLDG CO L 18.9%

Value ($000) $63,661 Shares 1,870,743 Est. Cost $47.23 Unrealized —

— ACCELERATE DIAGNOSTICS INC 10.2%

Value ($000) $34,172 Shares 4,102,287 Est. Cost $22.26 Unrealized —

— AGENUS INC 3.9%

Value ($000) $13,134 Shares 5,360,867 Est. Cost $2.71 Unrealized —

— SOLENO THERAPEUTICS INC 2.7%

Value ($000) $9,212 Shares 3,870,627 Est. Cost $1.78 Unrealized —

— VERMILLION INC 2.4%

Value ($000) $8,179 Shares 9,825,289 Est. Cost $1445.80 Unrealized —

— AMARIN CORP PLC 2.2%

Value ($000) $7,343 Shares 1,835,639 Est. Cost $582.46 Unrealized —

OPK OPKO HEALTH INC 1.8%

Value ($000) $5,994 Shares 4,473,076 Est. Cost $5.29 Unrealized -70.4%

— QUIDEL CORP 1.2%

Value ($000) $3,877 Shares 157,400 Est. Cost $24542.18 Unrealized —

PACB PACIFIC BIOSCIENCES CALIF IN 1.1%

Value ($000) $3,734 Shares 1,220,359 Est. Cost $4.77 Unrealized -14.2%

— ANTARES PHARMA INC 0.9%

Value ($000) $2,896 Shares 1,227,114 Est. Cost $3.35 Unrealized —

— MOTUS GI HLDGS INC 0.8%

Value ($000) $2,565 Shares 3,806,666 Est. Cost $3.08 Unrealized —

— BIOLASE INC 0.6%

Value ($000) $1,940 Shares 5,173,250 Est. Cost $1.21 Unrealized —

BIIB BIOGEN INC 0.5%

Value ($000) $1,540 Shares 4,868 Est. Cost $213.68 Unrealized +42.0%

— CONTRAFECT CORP 0.2%

Value ($000) $742 Shares 128,845 Est. Cost $5.76 Unrealized —

— Y-MABS THERAPEUTICS INC 0.2%

Value ($000) $658 Shares 25,212 Est. Cost $26.10 Unrealized —

— BIOHAVEN PHARMACTL HLDG CO L 0.1%

Value ($000) $218 Shares 100,000 Est. Cost $47.23 Unrealized —

— ACCELERATE DIAGNOSTICS INC 0.0%

Value ($000) $55 Shares 388,400 Est. Cost $22.26 Unrealized —

— AMARIN CORP PLC 0.0%

Value ($000) $2 Shares 351,000 Est. Cost $582.46 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
—	QUIDEL CORP	1,805,983	$176,643	52.5%	$24542.18	—	COM	74838J101
—	BIOHAVEN PHARMACTL HLDG CO L	1,870,743	$63,661	18.9%	$47.23	—	COM	G11196105
—	ACCELERATE DIAGNOSTICS INC	4,102,287	$34,172	10.2%	$22.26	—	COM	00430H102
—	AGENUS INC	5,360,867	$13,134	3.9%	$2.71	—	COM NEW	00847G705
—	SOLENO THERAPEUTICS INC	3,870,627	$9,212	2.7%	$1.78	—	COM NEW	834203200
—	VERMILLION INC	9,825,289	$8,179	2.4%	$1445.80	—	COM NEW	92407M206
—	AMARIN CORP PLC	1,835,639	$7,343	2.2%	$582.46	—	SPONS ADR NEW	023111206
OPK	OPKO HEALTH INC	4,473,076	$5,994	1.8%	$5.29	-70.4%	COM	68375N103
—	QUIDEL CORP	157,400	$3,877	1.2%	$24542.18	—	Call	74838J101
PACB	PACIFIC BIOSCIENCES CALIF IN	1,220,359	$3,734	1.1%	$4.77	-14.2%	COM	69404D108
—	ANTARES PHARMA INC	1,227,114	$2,896	0.9%	$3.35	—	COM	036642106
—	MOTUS GI HLDGS INC	3,806,666	$2,565	0.8%	$3.08	—	COM	62014P108
—	BIOLASE INC	5,173,250	$1,940	0.6%	$1.21	—	COM NEW	090911207
BIIB	BIOGEN INC	4,868	$1,540	0.5%	$213.68	+42.0%	COM	09062X103
—	CONTRAFECT CORP	128,845	$742	0.2%	$5.76	—	COM NEW	212326300
—	Y-MABS THERAPEUTICS INC	25,212	$658	0.2%	$26.10	—	COM	984241109
—	BIOHAVEN PHARMACTL HLDG CO L	100,000	$218	0.1%	$47.23	—	Call	G11196105
—	ACCELERATE DIAGNOSTICS INC	388,400	$55	0.0%	$22.26	—	Call	00430H102
—	AMARIN CORP PLC	351,000	$2	0.0%	$582.46	—	Call	023111206